IL186468A - Method of forming a complement image of a master - Google Patents
Method of forming a complement image of a masterInfo
- Publication number
- IL186468A IL186468A IL186468A IL18646807A IL186468A IL 186468 A IL186468 A IL 186468A IL 186468 A IL186468 A IL 186468A IL 18646807 A IL18646807 A IL 18646807A IL 186468 A IL186468 A IL 186468A
- Authority
- IL
- Israel
- Prior art keywords
- molecules
- substrate
- master
- bonds
- functional group
- Prior art date
Links
- 230000000295 complement effect Effects 0.000 title claims description 93
- 238000000034 method Methods 0.000 title claims description 69
- 239000000758 substrate Substances 0.000 claims description 198
- 125000000524 functional group Chemical group 0.000 claims description 54
- 125000006850 spacer group Chemical group 0.000 claims description 34
- -1 hapten Proteins 0.000 claims description 31
- 102000004190 Enzymes Human genes 0.000 claims description 22
- 108090000790 Enzymes Proteins 0.000 claims description 22
- 229910052751 metal Inorganic materials 0.000 claims description 16
- 239000002184 metal Substances 0.000 claims description 16
- 239000004215 Carbon black (E152) Substances 0.000 claims description 13
- 229930195733 hydrocarbon Natural products 0.000 claims description 13
- 238000006664 bond formation reaction Methods 0.000 claims description 12
- 229910052739 hydrogen Inorganic materials 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 239000000427 antigen Substances 0.000 claims description 11
- 108091007433 antigens Proteins 0.000 claims description 11
- 102000036639 antigens Human genes 0.000 claims description 11
- 150000001720 carbohydrates Chemical class 0.000 claims description 11
- 235000014633 carbohydrates Nutrition 0.000 claims description 11
- 239000001257 hydrogen Substances 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 102000004856 Lectins Human genes 0.000 claims description 9
- 108090001090 Lectins Proteins 0.000 claims description 9
- 239000002523 lectin Substances 0.000 claims description 9
- 229910044991 metal oxide Inorganic materials 0.000 claims description 9
- 150000004706 metal oxides Chemical class 0.000 claims description 9
- 239000005556 hormone Substances 0.000 claims description 8
- 229940088597 hormone Drugs 0.000 claims description 8
- 150000002430 hydrocarbons Chemical class 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 239000000376 reactant Substances 0.000 claims description 5
- 150000001336 alkenes Chemical class 0.000 claims description 4
- 230000000593 degrading effect Effects 0.000 claims description 4
- 238000000151 deposition Methods 0.000 claims description 4
- 239000012636 effector Substances 0.000 claims description 4
- 238000000609 electron-beam lithography Methods 0.000 claims description 4
- 150000008282 halocarbons Chemical class 0.000 claims description 4
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 4
- 239000000411 inducer Substances 0.000 claims description 4
- 239000003112 inhibitor Substances 0.000 claims description 4
- 239000002344 surface layer Substances 0.000 claims description 4
- 229910018830 PO3H Inorganic materials 0.000 claims description 2
- 125000003636 chemical group Chemical group 0.000 claims 3
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 description 67
- 108020004414 DNA Proteins 0.000 description 61
- 239000000243 solution Substances 0.000 description 50
- 108020004707 nucleic acids Proteins 0.000 description 42
- 102000039446 nucleic acids Human genes 0.000 description 42
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 26
- 125000003118 aryl group Chemical group 0.000 description 24
- 108091028043 Nucleic acid sequence Proteins 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 17
- 229910052737 gold Inorganic materials 0.000 description 17
- 239000010931 gold Substances 0.000 description 17
- 108091093037 Peptide nucleic acid Proteins 0.000 description 16
- 238000004519 manufacturing process Methods 0.000 description 16
- 125000001072 heteroaryl group Chemical group 0.000 description 15
- 230000033458 reproduction Effects 0.000 description 14
- 239000011780 sodium chloride Substances 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- 239000007984 Tris EDTA buffer Substances 0.000 description 12
- 125000002947 alkylene group Chemical group 0.000 description 12
- 125000003710 aryl alkyl group Chemical group 0.000 description 12
- 125000000217 alkyl group Chemical group 0.000 description 10
- 125000003835 nucleoside group Chemical group 0.000 description 9
- 108091023037 Aptamer Proteins 0.000 description 8
- 108060004795 Methyltransferase Proteins 0.000 description 8
- 125000003342 alkenyl group Chemical group 0.000 description 8
- 125000004450 alkenylene group Chemical group 0.000 description 8
- 125000004419 alkynylene group Chemical group 0.000 description 8
- 125000000732 arylene group Chemical group 0.000 description 8
- 125000004474 heteroalkylene group Chemical group 0.000 description 8
- 125000005549 heteroarylene group Chemical group 0.000 description 8
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 8
- 125000006588 heterocycloalkylene group Chemical group 0.000 description 8
- 125000003729 nucleotide group Chemical group 0.000 description 8
- 150000003573 thiols Chemical group 0.000 description 8
- 238000012546 transfer Methods 0.000 description 8
- 125000000304 alkynyl group Chemical group 0.000 description 7
- 230000003993 interaction Effects 0.000 description 7
- 239000010445 mica Substances 0.000 description 7
- 229910052618 mica group Inorganic materials 0.000 description 7
- 239000002777 nucleoside Substances 0.000 description 7
- 125000001424 substituent group Chemical group 0.000 description 7
- 125000003396 thiol group Chemical group [H]S* 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 6
- 125000004446 heteroarylalkyl group Chemical group 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- 102000053602 DNA Human genes 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 238000000089 atomic force micrograph Methods 0.000 description 5
- 230000027455 binding Effects 0.000 description 5
- 238000000979 dip-pen nanolithography Methods 0.000 description 5
- 150000002739 metals Chemical class 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000004065 semiconductor Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 125000002837 carbocyclic group Chemical group 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 125000005647 linker group Chemical group 0.000 description 4
- 238000005329 nanolithography Methods 0.000 description 4
- 125000006574 non-aromatic ring group Chemical group 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000007639 printing Methods 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 239000002356 single layer Substances 0.000 description 4
- 102100035631 Bloom syndrome protein Human genes 0.000 description 3
- 108090000133 DNA helicases Proteins 0.000 description 3
- 102000003844 DNA helicases Human genes 0.000 description 3
- 238000000018 DNA microarray Methods 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 3
- 108020004682 Single-Stranded DNA Proteins 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 3
- 230000009881 electrostatic interaction Effects 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- PMBXCGGQNSVESQ-UHFFFAOYSA-N n-hexyl mercaptan Natural products CCCCCCS PMBXCGGQNSVESQ-UHFFFAOYSA-N 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 239000013545 self-assembled monolayer Substances 0.000 description 3
- 229910000077 silane Inorganic materials 0.000 description 3
- INOAASCWQMFJQA-UHFFFAOYSA-N 16-sulfanylhexadecanoic acid Chemical compound OC(=O)CCCCCCCCCCCCCCCS INOAASCWQMFJQA-UHFFFAOYSA-N 0.000 description 2
- JRYMOPZHXMVHTA-DAGMQNCNSA-N 2-amino-7-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-pyrrolo[2,3-d]pyrimidin-4-one Chemical compound C1=CC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O JRYMOPZHXMVHTA-DAGMQNCNSA-N 0.000 description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N 4-methyl-1h-indole Chemical compound CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
- UGZAJZLUKVKCBM-UHFFFAOYSA-N 6-sulfanylhexan-1-ol Chemical compound OCCCCCCS UGZAJZLUKVKCBM-UHFFFAOYSA-N 0.000 description 2
- HDZZVAMISRMYHH-UHFFFAOYSA-N 9beta-Ribofuranosyl-7-deazaadenin Natural products C1=CC=2C(N)=NC=NC=2N1C1OC(CO)C(O)C1O HDZZVAMISRMYHH-UHFFFAOYSA-N 0.000 description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 239000005046 Chlorosilane Substances 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 2
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 2
- 101710116602 DNA-Binding protein G5P Proteins 0.000 description 2
- 241000701832 Enterobacteria phage T3 Species 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- 101000580659 Homo sapiens ATP-dependent DNA helicase Q1 Proteins 0.000 description 2
- 101000803270 Homo sapiens Bloom syndrome protein Proteins 0.000 description 2
- 229930010555 Inosine Natural products 0.000 description 2
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 239000004721 Polyphenylene oxide Substances 0.000 description 2
- 101710162453 Replication factor A Proteins 0.000 description 2
- 101710176758 Replication protein A 70 kDa DNA-binding subunit Proteins 0.000 description 2
- 101710176276 SSB protein Proteins 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 101710126859 Single-stranded DNA-binding protein Proteins 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 2
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 150000007942 carboxylates Chemical class 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- KOPOQZFJUQMUML-UHFFFAOYSA-N chlorosilane Chemical compound Cl[SiH3] KOPOQZFJUQMUML-UHFFFAOYSA-N 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 102000043885 human RECQL Human genes 0.000 description 2
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical compound C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- 229960003786 inosine Drugs 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000000813 microcontact printing Methods 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 125000002971 oxazolyl group Chemical group 0.000 description 2
- 229910052760 oxygen Chemical group 0.000 description 2
- 239000001301 oxygen Chemical group 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 239000008057 potassium phosphate buffer Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000010079 rubber tapping Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000001338 self-assembly Methods 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Chemical group 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- HDZZVAMISRMYHH-KCGFPETGSA-N tubercidin Chemical compound C1=CC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O HDZZVAMISRMYHH-KCGFPETGSA-N 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- KYJLJOJCMUFWDY-UUOKFMHZSA-N (2r,3r,4s,5r)-2-(6-amino-8-azidopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound [N-]=[N+]=NC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O KYJLJOJCMUFWDY-UUOKFMHZSA-N 0.000 description 1
- STGXGJRRAJKJRG-JDJSBBGDSA-N (3r,4r,5r)-5-(hydroxymethyl)-3-methoxyoxolane-2,4-diol Chemical compound CO[C@H]1C(O)O[C@H](CO)[C@H]1O STGXGJRRAJKJRG-JDJSBBGDSA-N 0.000 description 1
- RKSLVDIXBGWPIS-UAKXSSHOSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 RKSLVDIXBGWPIS-UAKXSSHOSA-N 0.000 description 1
- PISWNSOQFZRVJK-XLPZGREQSA-N 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2-sulfanylidenepyrimidin-4-one Chemical compound S=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 PISWNSOQFZRVJK-XLPZGREQSA-N 0.000 description 1
- MXHRCPNRJAMMIM-ULQXZJNLSA-N 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-tritiopyrimidine-2,4-dione Chemical compound O=C1NC(=O)C([3H])=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 MXHRCPNRJAMMIM-ULQXZJNLSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- AKIZPWSPNKVOMT-UHFFFAOYSA-N 1-sulfanylhexan-1-ol Chemical compound CCCCCC(O)S AKIZPWSPNKVOMT-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 1
- CKTSBUTUHBMZGZ-SHYZEUOFSA-N 2'‐deoxycytidine Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 CKTSBUTUHBMZGZ-SHYZEUOFSA-N 0.000 description 1
- ZDTFMPXQUSBYRL-UUOKFMHZSA-N 2-Aminoadenosine Chemical compound C12=NC(N)=NC(N)=C2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O ZDTFMPXQUSBYRL-UUOKFMHZSA-N 0.000 description 1
- MWBWWFOAEOYUST-UHFFFAOYSA-N 2-aminopurine Chemical compound NC1=NC=C2N=CNC2=N1 MWBWWFOAEOYUST-UHFFFAOYSA-N 0.000 description 1
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- RHFUOMFWUGWKKO-XVFCMESISA-N 2-thiocytidine Chemical compound S=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 RHFUOMFWUGWKKO-XVFCMESISA-N 0.000 description 1
- GJTBSTBJLVYKAU-XVFCMESISA-N 2-thiouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=S)NC(=O)C=C1 GJTBSTBJLVYKAU-XVFCMESISA-N 0.000 description 1
- ZLOIGESWDJYCTF-UHFFFAOYSA-N 4-Thiouridine Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=S)C=C1 ZLOIGESWDJYCTF-UHFFFAOYSA-N 0.000 description 1
- XXSIICQLPUAUDF-TURQNECASA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-prop-1-ynylpyrimidin-2-one Chemical compound O=C1N=C(N)C(C#CC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 XXSIICQLPUAUDF-TURQNECASA-N 0.000 description 1
- HRDXGYQCVPZEJE-UAKXSSHOSA-N 4-amino-5-bromo-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one Chemical compound C1=C(Br)C(N)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 HRDXGYQCVPZEJE-UAKXSSHOSA-N 0.000 description 1
- ZLOIGESWDJYCTF-XVFCMESISA-N 4-thiouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=S)C=C1 ZLOIGESWDJYCTF-XVFCMESISA-N 0.000 description 1
- AGFIRQJZCNVMCW-UAKXSSHOSA-N 5-bromouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 AGFIRQJZCNVMCW-UAKXSSHOSA-N 0.000 description 1
- FHIDNBAQOFJWCA-UAKXSSHOSA-N 5-fluorouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 FHIDNBAQOFJWCA-UAKXSSHOSA-N 0.000 description 1
- KDOPAZIWBAHVJB-UHFFFAOYSA-N 5h-pyrrolo[3,2-d]pyrimidine Chemical compound C1=NC=C2NC=CC2=N1 KDOPAZIWBAHVJB-UHFFFAOYSA-N 0.000 description 1
- ZKBQDFAWXLTYKS-UHFFFAOYSA-N 6-Chloro-1H-purine Chemical compound ClC1=NC=NC2=C1NC=N2 ZKBQDFAWXLTYKS-UHFFFAOYSA-N 0.000 description 1
- UEHOMUNTZPIBIL-UUOKFMHZSA-N 6-amino-9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7h-purin-8-one Chemical compound O=C1NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O UEHOMUNTZPIBIL-UUOKFMHZSA-N 0.000 description 1
- WYXSYVWAUAUWLD-SHUUEZRQSA-N 6-azauridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=N1 WYXSYVWAUAUWLD-SHUUEZRQSA-N 0.000 description 1
- OAUKGFJQZRGECT-UUOKFMHZSA-N 8-Azaadenosine Chemical compound N1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OAUKGFJQZRGECT-UUOKFMHZSA-N 0.000 description 1
- HCAJQHYUCKICQH-VPENINKCSA-N 8-Oxo-7,8-dihydro-2'-deoxyguanosine Chemical compound C1=2NC(N)=NC(=O)C=2NC(=O)N1[C@H]1C[C@H](O)[C@@H](CO)O1 HCAJQHYUCKICQH-VPENINKCSA-N 0.000 description 1
- MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
- 102100027452 ATP-dependent DNA helicase Q4 Human genes 0.000 description 1
- 102100038351 ATP-dependent DNA helicase Q5 Human genes 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 101100439299 Caenorhabditis elegans cgt-3 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- MIKUYHXYGGJMLM-UUOKFMHZSA-N Crotonoside Chemical compound C1=NC2=C(N)NC(=O)N=C2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O MIKUYHXYGGJMLM-UUOKFMHZSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- CKTSBUTUHBMZGZ-UHFFFAOYSA-N Deoxycytidine Natural products O=C1N=C(N)C=CN1C1OC(CO)C(O)C1 CKTSBUTUHBMZGZ-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 101000580577 Homo sapiens ATP-dependent DNA helicase Q4 Proteins 0.000 description 1
- 101000743497 Homo sapiens ATP-dependent DNA helicase Q5 Proteins 0.000 description 1
- 101001092125 Homo sapiens Replication protein A 70 kDa DNA-binding subunit Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- MRWXACSTFXYYMV-UHFFFAOYSA-N Nebularine Natural products OC1C(O)C(CO)OC1N1C2=NC=NC=C2N=C1 MRWXACSTFXYYMV-UHFFFAOYSA-N 0.000 description 1
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical group O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229930185560 Pseudouridine Natural products 0.000 description 1
- PTJWIQPHWPFNBW-UHFFFAOYSA-N Pseudouridine C Natural products OC1C(O)C(CO)OC1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-UHFFFAOYSA-N 0.000 description 1
- 108010012737 RecQ Helicases Proteins 0.000 description 1
- 102000019196 RecQ Helicases Human genes 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- IYABWNGZIDDRAK-UHFFFAOYSA-N allene Chemical group C=C=C IYABWNGZIDDRAK-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 101150099875 atpE gene Proteins 0.000 description 1
- 101150018639 atpFH gene Proteins 0.000 description 1
- 101150048329 atpH gene Proteins 0.000 description 1
- 229960002756 azacitidine Drugs 0.000 description 1
- 125000005334 azaindolyl group Chemical group N1N=C(C2=CC=CC=C12)* 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000005874 benzothiadiazolyl group Chemical group 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- WGDUUQDYDIIBKT-UHFFFAOYSA-N beta-Pseudouridine Natural products OC1OC(CN2C=CC(=O)NC2=O)C(O)C1O WGDUUQDYDIIBKT-UHFFFAOYSA-N 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 239000004068 calcium phosphate ceramic Substances 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- WUPRCGRRQUZFAB-DEGKJRJSSA-N corrin Chemical group N1C2CC\C1=C\C(CC/1)=N\C\1=C/C(CC\1)=N/C/1=C\C1=NC2CC1 WUPRCGRRQUZFAB-DEGKJRJSSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- ZSWFCLXCOIISFI-UHFFFAOYSA-N cyclopentadiene Chemical group C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 1
- 229960000684 cytarabine Drugs 0.000 description 1
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 108091070619 helicase family Proteins 0.000 description 1
- 102000040620 helicase family Human genes 0.000 description 1
- 125000004404 heteroalkyl group Chemical group 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 102000057074 human RPA1 Human genes 0.000 description 1
- DCPMPXBYPZGNDC-UHFFFAOYSA-N hydron;methanediimine;chloride Chemical compound Cl.N=C=N DCPMPXBYPZGNDC-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000005945 imidazopyridyl group Chemical group 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 150000002527 isonitriles Chemical class 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 238000002032 lab-on-a-chip Methods 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 150000001247 metal acetylides Chemical class 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000002082 metal nanoparticle Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000002071 nanotube Substances 0.000 description 1
- 239000002070 nanowire Substances 0.000 description 1
- MRWXACSTFXYYMV-FDDDBJFASA-N nebularine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC=C2N=C1 MRWXACSTFXYYMV-FDDDBJFASA-N 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 150000004767 nitrides Chemical class 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000001020 plasma etching Methods 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- PTJWIQPHWPFNBW-GBNDHIKLSA-N pseudouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-GBNDHIKLSA-N 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229910052702 rhenium Inorganic materials 0.000 description 1
- WUAPFZMCVAUBPE-UHFFFAOYSA-N rhenium atom Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- RHFUOMFWUGWKKO-UHFFFAOYSA-N s2C Natural products S=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 RHFUOMFWUGWKKO-UHFFFAOYSA-N 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 125000005888 tetrahydroindolyl group Chemical group 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 description 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F7/00—Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
- G03F7/0002—Lithographic processes using patterning methods other than those involving the exposure to radiation, e.g. by stamping
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00385—Printing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00387—Applications using probes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/00527—Sheets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00585—Parallel processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00596—Solid-phase processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00659—Two-dimensional arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00677—Ex-situ synthesis followed by deposition on the substrate
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00722—Nucleotides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00725—Peptides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00729—Peptide nucleic acids [PNA]
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Composite Materials (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Mathematical Physics (AREA)
- Theoretical Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Manufacturing & Machinery (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Printing Plates And Materials Therefor (AREA)
- Printing Methods (AREA)
Description
NANOCONTACT PRINTING Pearl Cohen Zedek Latzer P-8698-1L O 2006 112 1 Nanocontact Printing Background of the Invention In recent years, there has been considerable effort aimed at understanding new phenomena in the nanoscale, a diversity of new nanostructured materials have been fabricated and characterized. New devices with mtriguing properties are just beginning to be engineered. The expectations for a new generation of cheap and innovative tools that will change our lives are very high. The combination of a new set of expected and unexpected properties together with a whole new family of materials and fabrication methods will enable devices that we could not even have conceived just ten years ago. Coulomb blockade in metal nanoparticles as well as in semiconductor quantum dots, narrow band fluorescence emission from semiconductor nanoparticles, quantized ballistic conduction in nanowires and nanotubes are just a few new materials/phenomena that will have an impact on the way we design optical and electronics devices. For a review of nanodevices and fabrication techniques, see Bashir, Superlattice and Microstructures (2001), 2P(1):1-16; Xia, et al, Chem. Rev. (1999), 99:1823-1848; and Gonsalves, et al, Advanced Materials (2001), iJ(10):703-714, the entire teachings of which are incorporated herein by reference.
The first stages of nanoscience and mainly of nanotechnology have been dominated by the development and characterization of new materials and devices based on inorganic semiconductors and metals. One reason for this is that e-beam lithography, one of the first tools that could build nanometer scale structures and devices, is a technique to pattern inorganic materials on an inorganic substrate. A significant advancement in recent years has been the development of novel highly versatile nanolithographies based on scanning probe microscopes (SPM). Using various types of SPMs a wide variety of organic and inorganic substrates can now be patterned either by inducing localized chemical modifications or by forming self-assembled monolayers (SAMs). For example, Mirkin and coworkers have developed an atomic force microscope (AFM)-based technique (Dip Pen Nanolithography, DPN) in which a SAM can be generated by controlled transfer of molecules from the microscope tip to a substrate, with resolution below 5 nm (see Lee, et al., Science (2002), 295: 1702-1705; Demers, et al., Angew. Chem. Int. Ed (2001), 40(16):3O69-3071; Hong, et al, Science (1999), 255:523-525; Piner, et al., Science (1999), 283:661- 663; Demers, et al., Angew. Chem. Int. Ed. (2001), 40(16):3071-3073; Demers, et ai, Science (2002), P6.-183 -1838, U.S. Patent Application Publication Nos. 2002/0063212, 2003/0049381, 2003/0068446, and 2003/0157254, the entire teachings of which are incorporated herein by reference). The development of such techniques represents a major breakthrough, as now it is possible to build devices based not only on inorganic but also on organic and biomaterials. Organic based nanomaterials are likely to offer a number of interesting properties that can be effectively modulated on the nanoscale. Thanks both to these novel fabrication techniques and to the elucidation of basic concepts in surface and supra-molecular chemistry, novel devices are currently well under development.
Using organic and inorganic based nano-lithography techniques, many different nano-devices (e.g nano-transistors, nano-sensors and nano- waveguides) are presently being fabricated. However, in order to predict how great an impact nanotechnology will have, one must estimate the speed of fabrication for complex devices. It has been postulated that device fabrication time (and reproducibility) will be the main limiting factor in nanotechnology. In particular, the problem of how to scale up production has not been solved.
It would be desirable for nanotechnology to have an equivalent of micro-contact printing: the stamping technique engineered by Whitesides and coworkers (see U.S. Patent Nos. 5,512,131, 5,900,160, 6,048,623, 6,180,239, 6,322,979, 6,518,168, the entire teachings of which are incorporated herein by reference) has revolutionized the way people design micro-devices and has had an enormous impact in allowing non-chemist to build devices as complex as bio-MEMS. Unfortunately, micro-contact printing has some resolution limitations that limit its application in nanotechnology. Chou and coworkers at Princeton recently addressed this problem. Their method, discussed in U.S. Patent Nos. 5,772,905 and 6,309,580, and U.S. Patent Application Publication Nos. 2002/0167117, 2003/0034329, 2003/0080471, and 2003/0080472, the entire teachings of which are incorporated herein by reference, is based on a hard mold (i.e., a mold made of an inorganic material) that is stamped on a soft polymer film overcoating a silicon wafer. The printed substrates typically consist of metallic wires or U 2005 0123 semiconductor materials (see Chou, et al., Nature (2002), 417:835-837; and Austin, et al, J, Vac. Sci, Technol B (2002), 20(2) 665-667 , the entire teachings of which are incorporated herein by reference).
One drawback of existing nanolithography techniques for fabricating nanoscale devices is that features of many devices are fabricated in a series of steps. Thus, these techniques are useful for relatively simple devices, but the fabrication of devices having many features may take a prohibitive amount of time. One effort to address this problem is the fabrication of multi-tip arrays for SPMs (Zhang, et al, Nanotechnolog (2002), 13:2\2, the entire teachings of which are incorporated herein by reference). While such approaches may enable the parallel fabrication of a perhaps tens or hundreds of nano-devices, it would be desirable to develop a nanoscale stamping technique that better facilitates mass production by producing many features on a device in a single processing step.
Summary of the Invention The methods of the invention complement chemically oriented nanolithography techniques that have been developed in recent years and that often require complex instrumentation. For example, it has already been shown that DNA testing arrays can be fabricated using dip pen nanolithography. Once the master for these devices is built, the teachings of the invention can be used to print a large number of cheap and extremely sensitive devices for the detection of, for example, biohazards, without the need for complex instrumentation and materials. Because the transfer process is self-assembly based, all the steps, besides the fabrication of the master, can be done in parallel over very large areas and on multiple substrates.
In one aspect, the invention is a method of forming a complement image of a master. The method includes providing a master that comprises a first set of molecules bound to a first substrate to form a pattern. When the first set of molecules includes a nucleic acid, the first set of molecules includes a plurality of nucleic acids having different sequences. The method further includes assembling, via attractive forces or bond formation, a second set of molecules on the first set of molecules. Each molecule in the second set of molecules includes a reactive functional group and a recognition component that is attracted to or binds to one or more of the first set of molecules. The method further includes contacting the reactive functional group of the second set of molecules with a surface of a second substrate to form a bond between the second set of molecules and the second substrate, breaking the attractive force or bonds between the first set of molecules and the second set of molecules to form a complement image of the master, and optionally repeating the steps of assembling, contacting and breaking one or more times.
Each molecule of the second set of molecules may further include one or more of an exposed functionality, a covalent bond or first spacer that links the reactive functional group to the recognition component, or a covalent bond or a second spacer that links the exposed functionality to the recognition component. The second set of molecules may be assembled on the first set of molecules by contacting the master with a solution including the second set of molecules. For example, the master may be held in contact with the second substrate by capillary action of the solution containing the second set of molecules, and the attractive force or bonds between the first and second set of molecules may be broken by evaporating the solution.
The second set of molecules may include two or more different molecules that may have different recognition components, different exposed functionalities, or both. The two or more different molecules may form a pattern on the second substrate that has a profile that includes two or more heights. At least one of the two or more different molecules may include a first spacer and another of the two or more different molecules may either have a second spacer having a different length than the first spacer, or may lack a spacer. In alternative embodiments, the bonds between the first set of molecules and the second set of molecules may be broken by applying heat or by contacting the bonds with a solution having a high ionic strength.
In some embodiments, a component of each of the first set of molecules may be a nucleic acid sequence and the recognition component of the second set of molecules may be a nucleic acid sequence that is at least 80%, at least 90%, at least 95%, or at least 99% complementary to the nucleic acid sequence on the first set of molecules. The bonds between the first and second sets of molecules may be broken by contacting the bonds with an enzyme. The nucleic acid sequences may include DNA, K A, modified nucleic acid sequences, or combinations of these. The first set of molecules, second set of molecules, or both may include a peptide nucleic acid sequence.
The method may further include forming a pattern of one or more metals, metal oxides, or combinations of these on a surface of a substrate and contacting the surface with the first set of molecules. In this embodiment, each molecule of the first set of molecules has a reactive functional group that forms a bond between the metal or metal oxide and the molecules of the first set of molecules to form a master that includes a first set of molecules bound to the substrate to form a pattern.
In one embodiment, at least a portion of the second substrate surface may be free of the second set of molecules. The method may further include contacting the surface of the second substrate with a reactant selected to be chemically inert to the second set of molecules and to degrade at least the surface layer of the second substrate, thereby degrading the portion of the surface of the second substrate that is free of the second set of molecules, and removing the second set of molecules to uncover a portion of the surface of the second substrate. For example, the invention may include depositing a material on the portion of the second substrate surface that is free of the second set of molecules and removing the second set of molecules to uncover a portion of the surface of the second substrate. The attractive forces between the first and second sets of molecules may be magnetic.
In another aspect, the invention is a method of forming a reproduction of a master or a portion of a master. The method includes providing a master that includes a first set of molecules bound to a first substrate to form a pattern, assembling via bond formation a second set of molecules on the first set of molecules, contacting a reactive functional group of the second set of molecules with a surface of a second substrate to form a bond between the second set of molecules and a second substrate, breaking bonds between the first set of molecules and a recognition component on the second set of molecules to form a complement image of the master, assembling via bond formation a third set of molecules on the second set of molecules of the complement image, contacting a reactive functional group of the third set of molecules with a surface of a third substrate to form a bond between third set of molecules and the third substrate, breaking the bonds between the second set of molecules and a recognition component on the third set of molecules to form a reproduction of the master or a portion of the master, and optionally repeating the steps of assembling the third set of molecules, contacting the reactive group of the third set of molecules, and breaking the bonds between the second set of molecules and the third set of molecules one or more In another aspect, the invention is a composition including a first pattern of a first set of molecules bound to a first substrate and a complement image including a pattern of a second set of molecules bound to a second substrate via a reactive functional group on each molecule of the second set of molecules. When the first set of molecules includes a nucleic acid sequence, the first set of molecules includes a plurality of nucleic acids having different sequences and each molecule in the second set of molecules has a recognition component that binds to at least a portion of a molecule from the first set of molecules. The first substrate with the first pattern may be a reusable master.
In another aspect, the invention is a kit for printing a molecular pattern on a substrate. The kit includes a master including a pattern of a first set of molecules bound to a substrate and a second set of molecules, each of which includes a reactive functional group, and a recognition component that binds to the first set of molecules.
The amount of information stored in a molecule, such as a DNA strand, can be enormous. The method of the invention has the possibility of transferring this information in a massively parallel way (i.e., in one or only a few steps instead of many steps). Thus devices that are now built using multi-step techniques could be fabricated in a single step. This opportunity will redirect research and device manufacture towards increasing complexity in fabricated substrates. As a simple example, if a master were fabricated on a 1mm2 substrate having a series of, for example, 50 nano and microfluidic channels having 50 different types of DNA strands defining the walls of the channels, in one single printing step with the method of the invention, one could fabricate on a 1 mm2 substrate a complement image of the series of nano and microfluidic channels, each with the wall functionalized in a different way: a real lab on a chip.
A unique feature of the teachings of the invention is the ability to copy, and thus replicate, the master itself using the parallel method of the invention. This is a major advantage over any existing methods. Many masters are often needed for large production lines. This, combined with the wealing of existing molds, means that a constant production of masters is required. In the method of the invention, once a master is produced, reproductions of the master can be produced from it, and these new masters will then be used to print the final devices. Reproducibility should be improved, and the instruments for the primary master fabrication which produce features in a serial fashion will have to be used only ,to fabricate the primary master.
The method of the invention is revolutionary not only because it can be used to print organic S AMs, but because the method can be used to transfer multiple types of information (e.g., chemical + shape) and to reproduce a master in a parallel fashion.
Brief Description of the Drawing The invention is described with reference to a particular embodiment shown in the figures. The embodiment in the figures is shown by way of example and is not meant to be limiting in any way.
Figs. 1 A-D are a schematic representation of one embodiment of the method of the invention for producing a complement image.
Fig. 2 is a schematic representation of a first set of molecules bound to a second set of molecules.
Figs. 3 A and 3B are AFM images of a master having a monolayer of nucleic acid molecules bound to the surface of a substrate.
Fig. 3 C is an AFM image of a complement image of the master shown in Fig. 3A.
Fig. 3D is an AFM image of a complement image of the master shown in Fig. 3B.
Fig. 4A is an AFM image of a master having nucleic acids bound to a substrate in a grid pattern.
Fig. 4B is an AFM image of a complement image of the master shown in Fig. 4A.
Definitions A "master," as used herein, is a substrate that has a first set of molecules bound to a surface of the substrate in a random or non-random pattern. In one embodiment, the first set of molecules are bound to the master in a non-random pattern. The first set of molecules may include one or more different molecules. The information encoded in the pattern may be from the position of each of the molecules on the surface of the substrate and/or the chemical nature of the molecule (e.g., a molecule from the first set of molecules having a particular nucleic acid sequence will bind specifically to a nucleic acid molecule having a complementary sequence).
A "complement image of a master," as used herein, is an image on a substrate that is a rnirror image, when the pattern on the master is asymmetrical, or a copy, when the pattern on the master is symmetrical, of the spatial and/or chemical information encoded in the master, or a portion thereof. In one embodiment, the complement image is formed by binding a second set of molecules to a second substrate. For example, if the first set of molecules bound to the master are nucleic acid molecules that form a non-centrosymmetric pattern, a complement image of the master will be a mirror image of the master formed on a second substrate with a second set of molecules that are nucleic acids that have a sequence that is complementary to at least a portion of a nucleic acid sequence from the first set of molecules. In some embodiments, the chemical information transferred to the complement image is not identical to the information on the master but is enough information to allow at least a portion of the information from the master to be reproduced. For example, when the first and second sets of molecules are nucleic acid molecules, at least three or more consecutive bases of a molecule from the first set of molecules may be complementary to three or more consecutive bases from the second set of molecules. For example, at least 80%, at least 90%, at least 95%, or at least 99% of the nucleic acid sequences on the first and second sets of molecules may be complementary. A complement image can be formed from a portion of the pattern on the master by selecting molecules for the second set of molecules that only bind to a portion of the molecules of the first set of molecules that are bound to the master. When the second set of molecules binds only to a portion of the first set of molecule, the height profile of the complement image may have two or more levels. In addition, a complement image may encode only mirror image of the spatial information encoded in the master or may encode both the chemical and spatial information encoded in the master. For example, if the first set of molecules bound to the master are nucleic acid molecules that form an asymmetric pattern, a complement image of the master will be a mirror image of the master formed on a second substrate with a second set of molecules that are nucleic acids that have a sequence that is complementary to at least a portion of a nucleic acid sequence from the first set of molecules. In this example, both spatial and chemical information are transferred from the master to the complement image. - Furthermore, only a portion of the chemical information may be transferred to the complement image. For example, when the first set of molecules on the master are nucleic acid molecules, the second set of molecules that form the complement image may be nucleic acid sequences that are complementary to only a portion of a nucleic acid sequence on the master (e.g., not complementary to the whole sequence).
A "reproduction of a master," as used herein, is copy of the spatial and/or chemical information encoded in a pattern of a master. The reproduction may be a copy of only a portion of the pattern of the master or may be a copy of the entire pattern of the master. In addition, a reproduction of a master may copy only the spatial information of the master or may copy both the spatial and chemical information encoded in the master. In addition, a reproduction of a master may reproduce only part of the chemical information.
"Chemical information encoded in a molecule" refers to the ability of the molecule to bind specifically to another molecule or to a specific type of molecule, typically, in a specific conformation. For example, a particular nucleic acid sequence may bind specifically to a complementary sequence, or protein A may bind specifically to immunoglobulins.
The term "pattern," as used herein, refers to the spatial location of each molecule in a set of molecules bound to a substrate, and the chemical structure of each molecule in the set of molecules.
The term "silane," as used herein, refers to a functional group having the following structural formula: R,2 in the above structural formula, for each occurrence, is independently selected from the group consisting of-H, an alkyl, an aryl, an alkenyl, an alkynyl, and an arylalkyl.
The term "chlorosilane," as used herein, refers to a functional group having the following structural formula: ¾ in the above structural formula, for each occurrence, is independly selected from -CI or -OR.2, provided that at least one of Rg is -CI. Preferably, each Re is -CI.
The term "spacer," as used herein, refers to a divalent group that connects two components of a molecule. Exemplary spacers include alkylene, a heteroalkylene, a heterocycloalkylene, an alkenylene, an alkynylene, an arylene, a heteroaiylene, an arylalkylene, and a heteroarylalkylene, wherein the alkylene, heteroalkylene, heterocycloalkylene, alkenylene, alkynylene, arylene, heteroarylene, arylalkylene, or heteroarylalkylene may be substituted or unsubstituted.
The term "alkyl," as used herein, means a straight chained or branched Ci-C2o hydrocarbon or a cyclic C3-C20 hydrocarbon that is completely saturated. Alkyl groups may be substituted or unsubstituted.
The term "alkylene" refers to an alkyl group that has at least two points of attachment to at least two moieties (e.g., methylene, ethylene, isopropylene, etc.).
Alkylene groups may be substituted or unsubstituted.
"Alkenyl groups" are straight chained or branched C2-C20 hydrocarbon or a cyclic C3-C20 hydrocarbon that have one or more double bonds. Alkenyl groups may be substituted or unsubstituted.
An "alkenylene" refers to an alkenyl group that has two points of attachment to at least two moieties. Alkenylene groups may be substituted or unsubstituted.
"Alkynyl groups" are straight chained or branched C2-C20 hydrocarbon or a cyclic C3-C20 hydrocarbon that have one or more triple bonds. Alkynyl groups may be substituted or unsubstituted.
An "alkynylene" refers to an alkynyl gi'oup that has two points of attachment to at least two moieties. Alkynylene groups may be substituted or unsubstituted.
An "heteroalkylene" refers to a group having the formula -X-{(alkylene)-X}q-, wherein X is -0-, -NRi-, or -S-; and q is an integer form 1 to 10. j is a hydrogen, alkyl, aryl, arylalkyl, alkenyl, alkynyl, heteroaryl, heteroarylalkyl, or heterocycloalkyl. Heteroalkylene groups may be substituted or unsubstituted.
The term "aryl," as used herein, either alone or as part of another moiety (e.g., arylalkyl, etc.), refers to carbocyclic aromatic groups such as phenyl. Aryl groups also include fused polycyclic aromatic ring systems in which a carbocyclic aromatic ring is fused to another carbocyclic aromatic ring (e.g., 1 -naphthyl, 2-naphthyl, 1 -anthracyl, 2-anthracyl, etc.) or in which a carbocylic aromatic ring is fused to one or more carbocyclic non-aromatic rings (e.g., tetrahydronaphthylene, indan, etc.). The point of attachment of an arylene fused to a carbocyclic, non-aromatic ring may be on either the aromatic, non-aromatic ring. Aryl groups may be substituted or unsubstituted.
An "arylene" refers to an aryl group that has at least two points of attachment to at least two moieties (e.g., phenylene, etc.). Arylene groups may be substituted or unsubstituted.
An "arylalkyl" group refers to an aryl group that is attached to another moiety via an all ylene linker. Arylalkyl groups may be substituted or unsubstituted. When an arylalkylene is substituted, the substituents may be on either the aromatic ring or the alkylene portion of the arylalkyl.
An "arylalkylene group," as used herein, refers to an arylalkyl group that has at least two points of attachment to at least two moieties. The second points of attachment can be on either the aromatic ring or the alkylene. An arylalkylene may be substituted or unsubstituted. When an arylalkylene is substituted, the substituents may be on either the aromatic ring or the alkylene portion of the arylalkylene.
The term "heteroaryl," as used herein, means an aromatic heterocycle which contains 1, 2, 3 or 4 heteroatoms selected from nitrogen, sulfur or oxygen. A heteroaryl may be fused to one or two rings, such as a cycloalkyl, a heterocycloalkyl, an aryl, or a heteroaryl. The point of attachment of a heteroaryl to a molecule may be on the heteroaryl, cycloalkyl, heterocycloalkyl or aryl ring, and the heteroaryl group may be attached through carbon or a heteroatom. Examples of heteroaryl groups include imidazolyl, furyl, pyrrolyl, thienyl, oxazolyl, thiazolyl, isoxazolyl, thiadiazolyl, oxadiazolyl, pyridinyl, pvrirnidyl, pyrazinyl, pyridazinyl, quinolyl, isoquniolyl, indazolyl, benzoxazolyl, benzofuryl, benzothiazolyl, indolizinyl, iniidazopyridinyi, pyrazolyl, triazolyl, isothiazolyl, oxazolyl, tetrazolyl, benzimidazolyl, benzoxazolyl, benzothiazolyl, benzothiadiazolyl, benzoxadiazolyl, indolyl, tetrahydroindolyl, azaindolyl, imidazopyridyl, qtraizaolinyl, purinyl, pvrrolo[2,3]pyrirnidyl, pyra2Olo[3J4]pyrimidyl or benzo(b)thienyl each of which is optionally substituted. Heteroaryl groups may be substituted or unsubstituted.
A "heteroarylene" refers to an heteroaryl group that has at least two points of attachment to at least two moieties. Heteroarylene groups may be substituted or unsubstituted, A "heteroarylalkyl group" refers to an heteroaryl group that is attached to another moiety via an alkylene linker. Heteroarylalkyl groups may be substituted or unsubstituted. When a heteroarylalkylene is substituted, the substituents may be on either the aromatic ring or the allcylene portion of the heteroarylalkyl. Heteroarylalkyl groups may be substituted or unsubstituted.
A "heteroarylalkylene" refers to an heteroarylalkyl group that has at least two points of attachment to at least two moieties. Heteroarylalkylene groups may be substituted or unsubstituted.
A "heterocycloalkyl" refers to a non-aromatic ring which contains one or more, for example, one to four, oxygen, nitrogen or sulfur (e.g.,.morpholine, piperidine, piperazine, pyrrolidine, and thiomorpholine). Heterocycloalkyl groups may be substituted or unsubstituted.
A "heterocycloalkylene" refers to a heterocycloalkyl that has at least two points of attachment to at least two moieties. Heterocycloalkylene groups may be substituted or unsubstituted.
Suitable substituents for an alkyl, an allcylene, an alkenyl, an alkenylene, an alkynyl, an alkynylene, a heteroalkyl, a heteroalkylene, a heterocycloalkyl, a heterocycloalkylepe group, an aryl, an arylene group, an arylalkyl, an arylalkylene, a heteroaryl, a heteroarylene, a heteroarylallcyl, and a heteroaryalkylene groups include any substituent that is stable under the reaction conditions used in the method of the invention. Examples of substituents include an aryl (e.g., phenyl), an arylalkyl (e.g., benzyl), nitro, cyano, halo (e.g., fluorine, chlorine and bromine), alkyl (e.g., methyl, ethyl, isopropyl, cyclohexyl, etc.) haloalkyl (e.g., trifluoromethyl), alkoxy (e.g., methoxy, ethoxy, etc.), hydroxy, -NR3R , -NR3C(0) 5, -C(0)NR3IU, -C(0)R3, -C(0)OR3, -OC(0)Rs, wherein R3 and R4 for each occurrence are, independently, -H, an alkyl, an aryl, or an arylalkyl; and R5 for each occurrence is, independently, an alkyl, an aryl, or an arylalkyl.
Alkyl, alkylene, heterocycloalkylene groups, and any saturated portion of alkenyl, alkenylene, alkynyl, alkynylene groups, may also be substituted with =0 and =S.
When a heteroalkylene, a heterocycloalkyl, a heterocycloalkylene, a heteroaryl, or a heteroarylene group contain a nitrogen atom, it may be substituted or unsubstituted. When a nitrogen atom in the aromatic ring of a heteroaryl or a heteroarylene group has a substituent, the nitrogen may be a quaternary nitrogen.
The term "nucleic acids," or "oligonucleotides," as used herein, refers to a polymer of nucleotides. Typically, a nucleic acid comprises at least three nucleotides. The polymer may include natural nucleosides (i.e., adenosine, thymidine, guanosine, cytidine, uridine, deoxyadenosine, deoxythymidine, deoxyguanosine, and deoxycytidine) or modified nucleosides. Examples of modified nucleotides include base modified nucleoside (e.g., aracytidine, inosine, isoguanosine, nebularine, pseudouridine, 2,6-diaminopurine, 2-aminopurine, 2-thiomymidine, 3-deaza-5-azacytidine, 2'-deoxyuridine, 3-nitorpyrrole, 4-methylindole, 4-thiouridine, 4-thiot ymidine, 2-aminoadenosine, 2-thiothymidine, 2-thiouridine, 5-bromocytidine, 5-iodouridine, inosine, 6-azauridine, 6-chloropurine, 7-deazaadenosine, 7-deazaguanosine, 8-azaadenosine, 8-azidoadenosine, benzimidazole, Ml-methyladenosine, pyrrolo-pyrimidine, 2-amino-6-cMoropurine, 3-methyI adenosine, 5-propynylcytidine, 5-piOpynyluridine, 5-bromouridine, 5-fluorouridine, -methylcytidine, 7-deazaadenosine, 7-deazaguanosine, 8-oxoadenosine, 8-oxoguanosine, 0(6)-methylguanine, and 2-thiocytidine), chemically or biologically modified bases (e.g., methylated bases), modified sugars (e.g., 2'-fluororibose, 2'-aminoribose, 2 ' -azidoribose, 2 ' -O-methylribose, L-enantiomeric nucleosides arabinose, and hexose), modified phosphate groups (e.g., phosphorothioates and 5' -N-phosphoramidite linkages), and combinations thereof. Natural and modified nucleotide monomers for the chemical synthesis of nucleic acids are commercially available.
The term "peptide nucleic acid (PNA)," as used herein, refers to a polymer that has a peptide backbone in which a natural or non-natural nucleic acid base is attached to each arnino acid residue. Peptide nucleic acids are described in Hanvey, et ah, Science (1992), 2 5:1481-1485, the entire teachings of which are incorporated by reference. A PNA can bind specifically to a nucleic acid or another PNA that has a complementary sequence of at least three consecutive bases, for example, six consecutive bases, to the sequence of the PNA. In one embodiment, the PNA is at least 80%, at least 90%, at least 95%, or at least 99% complementary to the nucleic acid or second PNA.
The term "attractive force," as used herein, is a force that draws two or more molecules together. Examples of attractive forces include attraction of a molecule having a net positive charge to a molecule having a net negative charge, dipole-dipole attraction, and magnetic attraction.
Unless specified as a covalent bond, the term "bind" or "bound" includes both covalent and non-covalent associations, such as hydrogen bonds, ionic bonds, electrostatic interactions, magnetic interactions, covalent bonds, and van der Waals bonds.
The term "recognition component," as used herein, is a component of a molecule that can bind specifically to another molecule.
"Specific binding," as used herein, is when a recognition component of a molecule binds one or more other molecule or complex, with specificity sufficient to differentiate between the molecule or complex and other components or contaminants of a sample. Molecules that include recognition components and their targets are conventional and are not described here in detail. Techniques for preparing and utilizing such systems are well known in the art and are exemplified in the publication of Tijssen, P., "Laboratory Techniques in Biochemistry and Molecular Biology Practice and Theories of Enzyme Immunoassays" (1988), eds. Burdon and Knippenberg, New YorkrEIsevier, the entire teachings of which are incorporated herein. Exemplary recognition components and their targets include nucleic acid/complementary nucleic acid, antigen/antibody, antigen antibody fragment, avidin/biotin, streptavidin/biotin, protein A/Ig, lectin carbohydrate and aptamer/target.
As used herein, "aptamer" refers to a non-naturally occurring nucleic acid that binds selectively to a target. The nucleic acid that forms the aptamer may be composed of naturally occurring, nucleosides, modified nucleosides, naturally occurring nucleosides with hydrocarbon linkers (e.g., an alkylene) or a polyether linker (e.g., a PEG linker) inserted between one or more nucleosides, modified nucleosides with hydrocarbon or PEG linkers inserted between one or more nucleosides, or a combination of thereof. In one embodiment, nucleotides or modified nucleotides of the nucleic acid ligand can be replaced with a hydrocarbon linker or a polyether linker provided that the binding affinity and selectivity of the nucleic acid ligand is not substantially reduced by the substitution (e.g., the dissociation constant of the aptamer for the target should not be greater than about 1 x 10"6 M). The target molecule of a aptamer is a three dimensional chemical structure that binds to the aptamer. However, the aptamer is not simply a linear complementary sequence of a nucleic acid target but may include regions that bind via complementary Watson-Crick base pairing interrupted by other structures such as hairpin loops). Targets of aptamers include peptide, polypeptide, carbohydrate and nucleic acid molecules.
Detailed Description The method of the invention involves stamping of molecular patterns and/or devices based on the reversible self-assembly of molecules, particularly organic molecules. This method is suitable for the stamping of almost any nanofabricated device, inorganic ancL/or organic, and can be used to transferring a large amount of information from one substrate to another. The working principle of this technique is completely different from any present nanofabrication technique.
In one embodiment of the invention, a master that includes a substrate having a first set of molecules bound to at least one surface in a pattern, is used to induce the assembly of a second set of molecules via reversible supra-molecular chemistry (e.g., hydrogen bonds, ionic bonds, covalent bonds, electrostatic interactions, van der Waals interactions, magnetic interactions, or a combination thereof). With the use of substantially irreversible surface chemistry, the second set of molecules are attached to a surface of a substrate, and, subsequently the reversible bonds between the first set of molecules and the second set of molecules are broken. The term "substantially irreversible," as used herein, means that the second set of molecules are attached to the surface of the substrate by bonds that are stable under conditions that will break the bonds between the first and the second set of molecules. Supra-molecular bonds may be exploited as a mechanism for shape-transfer; this avoids the need for mechanical contact between the master and the substrate being stamped, and thus constitutes a major departure f om nano-imprinting developed by Chou and co-workers. This method is tailor-made to transfer organic patterns reliably. The use of organic molecules allows a great number of variations and enables the transfer of multiple surface features at the same time.
Referring to Fig. 1, in one embodiment, the method of forming a complement image of a master involves providing a master 10 that comprises a first set of molecules 12 bound to a first substrate 14 to form a pattern. The first set of molecules 12 may include a spacer 11 and a recognition component 13. A second set of molecules 16 is assembled on the first set of molecules via bond formation. The second set of molecules comprises a reactive functional group 18 and a recognition component 20 that binds to the recognition component 13 of the first set of molecules 12 (see Fig. 2, which provides a blowup of the second set of molecules bound to the first set of molecules). The reactive functional group 18 of the second set of molecules 16 is then contacted with a surface of a second substrate 22. The reactive functional group reacts with the surface of the second substrate to form a bond between the second set of molecules and the second substrate. In one embodiment, the remaining exposed surface of the second substrate may be further contacted with another group of molecules 24 that each have a reactive functional group, such as an alkane having a thiol substituent, e.g., mercaptohexanol, that can bind to the surface in order to cover the exposed surface of the second substrate. The bonds between the first set of molecules and the second set of molecules are then broken, and the second set of molecules bound to the second substrate forms a complement image 26 of the master 10. Once the master has been separated from the complement image by breaking the bonds between the first and the second set of molecules, the master can be reused one or more times to form additional complement images. In one embodiment, a lateral dimension of at least one feature of the complement image less 200 nm or less, for example, lOOnm or less, 50 nm or less, or 20nm or less.
In one embodiment, the second set of molecules may also include one or more of the following components: an exposed functionality 28; a covalent bond or a first spacer 30 that links the reactive functional group to the recognition component; and a covalent bond or a second spacer (need figure) that links the exposed functionality to the recognition component.
The second set of molecules may include two or more different molecules. For example, two or more molecules of the second set of molecules may have different recognition components, such as different nucleic acid sequences, or two or more molecules of the second set of molecules may have both different recognition components and different exposed functionalities. In some embodiments, one or more molecules from the first set of molecules determines where each of the molecules from the second set of molecules binds.
In one embodiment, the two or more different molecules of the second set of molecules form a pattern on the second substrate having a profile that includes two or more heights. For example, molecules in the second set of molecules may include spacers 30 of two or more different lengths. The difference in the length of the spacers may cause the molecular image transferred to the second substrate to vary by height.
In one embodiment, the second set of molecules is assembled on the first set of molecules by contacting the master with a solution comprising the second set of molecules. In one method of transferring the pattern on a master to a second substrate, the master is held in contact with the second substrate by capillary action of the solution containing the second set of molecules. A mechanical force, for example, from 10"3 Pa, to 1 GPa,may also be applied to hold the two substrates together. For example, the force may be on the order of about 10" Pa, 1 Pa, 1 Pa, 1 M Pa or 1 G Pa. The solution containing the second set of molecules is then slowly evaporated causing the master and the second substrate to come closer together and facilitating binding of the second set of molecules to the second substrate.
The bonds between the first set of molecules and the second set of molecules may be formed by hydrogen bonds, ionic bonds, covalent bonds, electrostatic interactions, van der Waals interactions, magnetic interactions, pi-bond interactions, or a combination thereof. In one embodiment, the bonds between the first set of molecules and the second set of molecules are broken by applying heat. Alternatively or in addition, the bonds between the first set of molecules and the second set of molecules are broken by contacting the bonds with a solution having a high ionic strength or a polar solvent. In yet another embodiment, the bonds between the first set of molecules and the second set of molecules are broken by contacting the bonds with a solution having a high ionic strength and applying heat. Alternatively, the bonds between the first set of molecules and the second set of molecules are broken by contacting them with a solution containing an enzyme that breaks the bonds. Typically, the bonds between the first set of molecules and the second set of molecules can be broken without brealcing most of the bonds between the second set of molecules and the second substrate.
The reactive functional group on the second set of molecules may be a group that can bind to the surface of the second substrate. For example, when the reactive functional group on the second set of molecules is a thiol group or a protected thiol group, the surface of the second substrate may be gold, silver, copper, cadmium, zinc, palladium, platinum, mercury, lead, iron, chromium, manganese, tungsten, or mixtures or alloys of any of these. The term "reactive functional group," as used herein, is a group that can react to form a bond with a surface of a substrate. Metiiods of protecting and deprotecting thiol groups can be found in Greene and Wuts, "Protective Groups in Organic Synthesis", John Wiley & Sons (1991), the entire teachings of which are incorporated into this application by reference. Protected thiol groups may be deprotected before reacting them with the substrate surface. In another example, the reactive functional group on the second set of molecules is a silane or a chlorosilane, and the surface of the second substrate is doped or undoped silicon, glass, fused silica, or any substrate with an oxidized surface, for example, silica, alumina, calcium phosphate ceramics, and hydroxylated polymers. Non-hydroxylated surfaces may be plasma etched to create oxidized groups that can react with silanes. In another example, the reactive functional group on the second set of molecules is a carboxylic acid, and the surface of the second substrate is an oxide, such as silica, alumina, quartz, or glass, or an oxidized polymeric surface. In another example, the reactive functional group on the second set of molecules is a nitrile or an isonitrile, and the surface of the second substrate is platinum, palladium or any alloy thereof. In another example, the reactive functional group on the second set of molecules is a hydroxamic acid, and the surface of the second substrate is copper or aluminum. Phosphonic acids may also be used to attach the second set of molecules to duininum substrates.
In one embodiment, at least some of the molecules of the first set of molecules include a recognition component (how long?) that binds to one or more molecules of the second set of molecules. For example, each of the molecules of the first set of molecules may include a recognition component that is a nucleic acid sequence. In one embodiment, each of the first set of molecules includes a nucleic acid sequence, for example, DNA, RNA, modified nucleic acid sequences or combinations of these, and the recognition component of the second set of molecules is a nucleic acid sequence. In one embodiment, the nucleic acid recognition component of each of the second set of molecules may be complementary to at least a portion of a nucleic acid sequence of at least one of the molecules from the first set of molecules. For example, three or more consecutive nucleic acid bases, e.g., six or more nucleic acid bases, of a molecule from the second set of molecules are complementary with three or more consecutive nucleic acid bases, e.g., six or more nucleic acid bases, of a molecule from the first set of molecules. In another example, at least 80%, at least 90%, at least 95%, or at least 99% of the nucleotides on the first set of molecules are complementary to those molecules from the second set of molecules to which they are bound. When the second set of molecules is assembled on the first set of molecules, the second set of molecules will hybridize with molecules from the first set of molecules that have a complementary sequence, or a portion thereof, to the nucleic acid recognition component of the second set of molecules. In this embodiment, the first set of molecules bound to the master is contacted with a solution of the second set of molecules under conditions that promote hybridization. Conditions that promote hybridization are known to those skilled in the art. A general description of hybridization conditions are discussed in Ausebel, F. M., et al., Current Protocols in Molecular Biology, Greene Publishing Assoc. and Wiley-Interscience, 1989, the teachings of which are incorporated herein by reference.
Factors such as sequence length, base composition, percent mismatch between the hybridizing sequences, temperature and ionic strength influence the stability of nucleic acid hybrids.
In one embodiment, the first set of molecules includes two or more different molecules mat have recognition components that are different nucleic acid sequences.
In this embodiment, the second set of molecules includes molecules that have a nucleic acid sequence, or a portion thereof, that is complementary to at least one of the molecules of the first set of molecules. In one embodiment, hydrogen bonds between hybridized molecules from the first set of molecules and the second set of molecules are broken by contacting the hydrogen bonds with an enzyme. For example, an enzyme from the helicase family of enzymes may be use to break the bonds between hybridized nucleic acid molecules. Various helicases have been reported to dehybridize double stranded oligonucleotides. For example, E. coli Rep, E. coli DnaB, E. coli UvrD (also known as Helicase II), E. coli RecBCD, E. coli RecQ, bacteriophage T7 DNA helicase, human RECQL series; N(RECQ2), BLM(RECQL3), RECQL4, RECQL5, S. Pombe rqhl, C. elegance T04A11.6 (typically, the helicase name is derived from the organism from which enzymes comes). Helicases can be divided into two types: 1) helicases that move along the nucleic acid strand in the 3' direction, and 2) helicases that more along the nucleic acid strand in the 5' direction. Typically, the particular type of helicase used to break the hydrogen bonds between the hybrided nucleic acids are selected by considering structural hindrance of the particular hybridized nucleic acids. Cofactors that stabilize single stranded DNA, such as single stranded DNA binding protein (SSB), may be added.
Another method of breaking the bonds between two hybridized nucleic acids is to use a restriction endonuclease, which recognizes a specific base sequence and cleaves both strands at a specific location in the nucleic acid sequence. Examples of restriction endonucleases include BamHI, EcoRI, and BstXI. Other methods of dehybridazition of nucleic acids using enzymes can be found in Lubert Stryer , Biochemistry, 4th Edition; Benjamin Lewin, Gene VII; Kristen Moore Picha and Smita S. Patel, "Bacteriophage T7 DNA Helicase Binds dTTP, Forms Hexamers, and Binds DNA in the Absence of Mg2+," J. Biol C em. (1998), Vol. 273, Issue 42, 27315-2731 ; Sheng Cui, Raffaella Klima, Alex Ochem, Daniele Arosio, Arturo Falaschi, and Alessandro Vindigni, "Characterization of the DNA-unwinding Activity of Human RECQ1, a Helicase Specifically Stimulated by Human Replication Protein A," J. Biol. Chem. (2003), Vol. 278, Issue 3, 1424-1432; Umezu, K., and Nakayama, H. (1993), J. Mol. Biol,. 230: 1145-1150; Nakayama, K., Irino, K, and Nakayama, H., Uol Gen. Genet. (1985), 200:266-271; Kusano, K., Berres, M. E., and Engels, W. R., Genetics W 2006 11 1 (1999), 15: 1027-1039; Ozsoy, A. Z., Sekelsky, J. J., and Matson, S. W., Nucleic Acids Res. (2001), 2P:2986-299, the entire teachings of these references is incorporated herein by reference.
In an alternative embodiment, a component of each of the first set of molecules is a peptide nucleic acid (PNA) sequence and the recognition component of the second set of molecules is a PNA sequence. Alternatively, a component of each of the molecules from the first set of molecules is a peptide nucleic acid (PNA) sequence and the recognition component of the second set of molecules is a nucleic acid sequence, or vice versa. PNA molecules hybridize to other PNA molecules and to nucleic acid sequences in a manner similar to that of nucleic acid hybridization to other nucleic acid. In one embodiment, at least one or more molecule from the second set of molecules must have at least three consecutive bases, e.g., six consecutive bases, that are complementary to at least three consecutive bases, e.g., six consecutive bases, of a molecule from the first set of molecules. In another example, at least 80%, at least 9%, at least 95%, or at least 99% of the nucleotides on the first set of molecules are complementary to those molecules from the second set of molecules to which they are bound.
Alternatively, the bonds between the first set of molecules and the second set of molecules are broken by applying heat, by contacting the bonds with a solution having a high ionic strength or polarity, by applying a magnetic or electric field, or any combination of the above.
When a set of molecules binds to the surface of a substrate, the molecules may fold or stack against one another such that a portion of the molecule will be exposed at the surface of the substrate. The exposed functionality may be hydrophobic, hydrophilic, or an amphipathic functionality. In addition, the exposed functionality may be a functionality that selectively binds various biological or other chemical species such as proteins, antibodies, antigens, sugars and other carbohydrates, and the like. The exposed functionality may comprise a member of any specific or non-specific binding pair, such as either member of the following non-limiting list: antibody/antigen, antibody hapten, enzyme/substrate, enzyme/inhibitor, enzyme/cofactor, binding protein substrate, carrier protein/substrate, lectin/carbohydrate, receptor/hormone, receptor/effector, complementary strands of nucleic acid, repressor/inducer, or the like. Other examples of exposed functionalities include but are not limited to -OH, -CONH-, -CONHCO-, -NH2, -NH-, -COOH, -COOR, -CSNH-, -N02", -S02, -SH, -RCOR-, -RCSR-, -RSR, -ROR-, -Ρθ -OS03'2, -SO3", -COO', -SOO', -RSOR-, -CONR2, -(OCH2CH2)nOH (where n=l-20, preferably 1-8), -CH3, -PO3H", -2-imidazole, -N(CH3)2, -N(R)2, -P03H2, -CN, -(CF2)„CF3 (where n=l-20, preferably 1-8), and olefins, where R is hydrogen, a hydrocarbon, a halogenated hydrocarbon, a protein, an enzyme, a carbohydrates, a lectin, a hormone, a receptor, an antigen, an antibody, or a hapten.
The exposed functionality may include a protecting group which may be removed to effect further modification of the complement image or the reproduction of the master. For example, a photoremovable protecting group may be used. A wide variety of positive light-reactive groups are known in the art, for example, nitroaromatic compounds such as o-nitrobenzyl derivatives or benzylsulfonyl.
Photoremovable protective groups are described in, for example, U.S. Pat. No. ,143,854, the entire teachings of which are incorporated herein by reference, as well as Patchornik, JACS, 92:6333 (1970) and Amit et al, JOC, 39:192, (1974), both of which are incorporated herein by reference.
In one embodiment, the complement image may be further modified by binding the exposed functional group of at least one of the second set of molecules to a metal or a metal ion. For example, the exposed functional group may include an amine, amide, nitrosyl, cyano, carbonyl, thiol, thiocarbonyl, selenocarbonyl, alkenyl, aryl, arylalkyl, heteroaryl, heteiOarylalkyl, or cyclopentadiene group at their end, or a linear or cyclic organic group having one or more double bonds or a conjugated pi system. These groups may be coordinated with atoms or ions of metals such as iron, cobalt, nickel, gold, silver, zinc, potassium, phosphorus, seleiiium, sodium, platinum, palladium, titanium, vanadium, molybdenum, magnesium, rhenium, ruthenium, and osmium. Where the appropriate chelating group is too large or otherwise not suited to being disposed on the second set of molecules during deposition, the second set of molecules may be modified to attach an appropriate chelating group to at least a portion of the molecules. For example, a porphyrin or corrin ring may be attached to at least a portion of the second set of molecules using the same coupling chemistries described below for attaching the recognition component of the second set of molecules to a spacer.
Alternatively or in addition, the second set of molecules may include a peptide sequence or a section of an enzyme or other protein whose function is to bind a metal atom or ion. In some embodiments, a metal atom or ion may be coordinated to functional groups on two, three, or more of the second set of molecules.
The first and second spacers of the first and second sets of molecules may be independently selected from the group consisting of an alkylene, a heteroalkylene, a heterocycloalkylene, an alkenylene, an alkynylene, an arylene, a heteroarylene, arylalkylene, and a heteroarylalkylene. The alkylene, heteroalkylene, heterocycloalkylene, alkenylene, alkynylene, arylene, heteroarylene, arylalkylene, and heteroarylalkylene spacers may be substituted or unsubstituted. In one embodiment, either the first or the second spacers, or both the first and the second spacers are substituted with one or more halogen and/or hydroxy.
In another embodiment, the substrate that is being deposited is fabricated with a spacer anchored to the substrate by a silane or other reactive functional group. The end of the spacer includes a reactive group such as epoxy or carboxylate. In this embodiment, the recognition component 20 of the second set of molecules includes a reactive group that reacts with the reactive group on the spacer to create a covalent bond between the spacer and the recognition component. For example, the recognition component may be an amine-terminated molecule, e.g., amine-terminated DNA.
Carboxyl-terminated molecules also react with epoxy groups to form an anhydride. Other chemistries that may be exploited to couple the second set of molecules to a set of spacers on a substrate include anhydride-hydroxyl, carbodiimide coupling, carboxylate reactions with amine, hydroxyl, and other groups, others? and other coupling reactions known to those skilled in the art. The reaction conditions may be selected to maintain the stability of the recognition component. For example, while some recognition components are not stable with respect to heat or particular solvents, they may be stable with respect to short exposures (e.g., a few hours) to such conditions. In some embodiments, the reactive groups on the ends of the second set of molecules and the spacer do not react with themselves to prevent the spacers or the molecules being deposited from attaching to one another instead of linking the second set of molecules to the substrate.
The master may be prepared by any method known to those skilled in the art (see Xia, et al, Chem. Rev. (1999), PP:1823-1848, the entire teachings of which are incorporated by reference). For example, the method of forming the master may be a nanopatterning method. In one embodiment, the master is prepared by forming a pattern of one or more metals, metal oxides, or combinations thereof on a surface of a substrate using electron beam lithography. The surface of the substrate is then contacted with a first set of molecules. In mis embodiment, each of the first set of molecules has a reactive functional group that forms a bond between the metal or metal oxide and the molecules of the first set of molecules, so that the first set of molecules binds to the substrate forming a master having a first set of molecules bound to the substrate to form a pattern. The reactive groups and substrate materials used to form the master may be the same or different than those used to pattern the second set of molecules.
Alternatively, the master can be prepared using dip pen nanolithography.
Methods of preparing molecularly patterned substrates using dip pen nanolithography are described in Schwartz, L ngmuir (2002), 75:4041-4046 and in Piner, et al, Science (1 99), 283:661-663, the entire teachings of both references are incorporated herein by reference.
Alternatively, the master can be prepared using replacement lithography, nanoshading or nanografting. These methods are described in Sun, et al, JACS (2002), 124(11):2414-2415; Amro, et al, Langmuir (2000), 5:3006-3009; Liu, et al, Nano Letters (2002), 2(8):863-867; and Liu, etal., Acc. Chem. Res. (2000), 53:457-466; the entire teachings of these references are incorporated herein by reference.
Another embodiment is a lithograpliic method in which at least one portion of the second substrate surface is free of the second set of molecules. In this embodiment, the exposed surface of the second substrate is contacted with a reactant selected to be chemically inert to the second set of molecules, which acts as a resist, and to degrade at least the surface layer of the second substrate, thereby degrading the portion of the surface of the second substrate that is free of the second set of molecules. For example, the reactant is a reactive ion etching compound. The second set of molecules is then removed to uncover a portion of the surface of the second substrate.
In another embodiment, at least one portion of the second substrate surface is free of the second set of molecules, and a material is deposited on the portion of the second substrate surface that is free of the second set of molecules. Examples of deposited material include semiconductors, dielectrics, metals, metal oxides, metal nitrides, metal carbides, and combinations thereof. The second set of molecules is then removed to uncover a portion of the surface of the second substrate.
In one aspect of the invention, the method of forming a complement image of a master involves assembling a second set of molecules via attractive forces on the first set of molecules. Examples of attractive forces include attraction of a molecule having a net positive charge to a molecule having a net negative charge, dipole-dipole attraction, and magnetic attraction. In one embodiment, the attractive force is a magnetic force. In one example, when the attractive force is a magnetic force, one or more molecules from the first set of molecules and from the second set of molecules include an iron or iron oxide component. In this embodiment, the attractive forces between the first set of molecules and the second set of molecules can be broken by applying a magnetic field.
In another aspect of the invention, the method involves forming a reproduction of a master, or a portion thereof. The master used in this embodiment of the method of the invention comprises a first set of molecules bound to a first substrate to form a pattern. A second set of molecules is assembled on the first set of molecules via bond formation. The second set of molecules comprises a reactive functional group and a recognition component that binds to the first set of molecules. The reactive functional group of the second set of molecules is then contacted with a surface of a second substrate. The reactive functional group reacts with the surface of the second substrate to form a bond between the second set of molecules and the second substrate. The bonds between the first set of molecules and the second set of molecules are then broken, and the second set of molecules bound to the second substrate forms a complement image of the master. A third set of molecules is then assembled via bond formation on the second set of molecules of the complement image. Each molecule in the third set of molecules comprises a reactive functional group, and a recognition component that binds to the second set of molecules. The reactive functional group of the third set of molecules is then contacted with a surface of a third substrate. The surface of the third substrate reacts with the reactive functional group of the third set of molecules to form a bond between the third set of molecules and the third substrate. The bonds between the second set of molecules and the third set of molecules are then broken, and the third set of molecules bound to the third substrate form a reproduction of the pattern, or portion thereof, of the master. Once the complement image has been separated form the reproduction, the complement image can be reused one or more times to form additional reproductions. In one embodiment, a lateral dimension of at least one feature of the reproduction is 200 nm or less, for example, 100 nm or less, 50 nm or less, or 20 nm or less.
The method of forming a reproduction is the same as that used to form a complement image except that the complement image of the master is used as a template (or "master") to transfer the pattern to the third substrates. Thus, the embodiments and examples disclosed above for the second set of molecules and the second substrate apply as well to the third set of molecules and the third substrate, respectively. In addition, examples of conditions for assembling the second set of molecules on the first set of molecules and for breaking the bonds between the first and the second set of molecules can apply equally as well to conditions for assembling the third set of molecules on the second set of molecules and for breaking the bonds between the third and the second set of molecules.
In another embodiment, the invention relates to a molecular printer for generating a complement image of a master, wherein the master has a first set of molecules bound to a first substrate. The molecular printer includes a device for delivering a solution of a second set of molecules to a surface of the master, and a device for contacting the second set of molecules with a second substrate. In this embodiment, the second set of molecules comprises a reactive functional group; and a recognition component that binds to the first set of molecules, we need some details on this The apparatus may include one or more reservoirs that contain the second set of molecules and one or more vessels or components for holding a master in position for delivery of me solution containing the second set of molecules. In addition, the apparatus may include a computer-controlled device for transferring the solution of the second set of molecules from the reservoirs to the surface using the master. A clamp that secures the master to the second substrate may also be included in the apparatus. The temperature of the solution of the second set of molecules and the vessel containing the master may also be controlled. The apparatus may also include a reservoir containing a solution for breaking the bonds between the first and the second molecules, such as a solution having a high ionic strength or a solution containing an enzyme that will break the bonds, and a device for delivering the solution. In addition, after the second substrate has been bound to the second set of molecules, a heating element may be used to heat a solution in contact with the bound first and second sets of molecules to break the bonds. The computer-controlled devices for transferring solutions and controlling temperature may be any of a variety of general purpose laboratory robots, such as those d sclosed by Harrison et al, Biotechniques, 14: 88-97 (1993); Fujita et al, Biotechniques, 9: 584-591 (1990); Wada et al, Rev. Sci. Instrum., 54: 1569-1572 (1983), the entire teachings of all of which are incorporated herein by reference. Suitable laboratory robots are also available commercially, e.g. Applied Biosystems model 800 Catalyst (Foster City, Calif.). In one embodiment, the apparatus also includes a device for separating the second substrate from the master after the bonds between the first set of molecules and the second set of molecules have been broken.
These and other aspects of the present invention will be further appreciated upon consideration of the following Examples, which are intended to illustrate certain particular embodiments of the invention but are not intended to limit its scope, as defined by the Claims.
EXAMPLES Example 1: Preparation of a Complement Image of a DNA Monolayer A. Preparation of DNA solutions All glassware was cleaned with a solution of 75% H2SO4 and 25%¾θ2 before use. All water used was ultrapure water (ΙδΜΩ cm).
The primary DNA, 5 V5-ThiolMC6-D/ACG CAA CTT CGG GCT CTT - 3\ were purchased from Integrated DNA Technologies, Inc. (IDT), Coraville, IA. All DNA strands were used as received from the manufacturer. The primary DNA was dissolved in water at the concentration of 1 μ^πΛ and divided into smaller aliquots of 50 μΐ,, and stored at -20°C. When a portion of this solution was used, an aliquot was reduced by placing it in a 40 m buffer solution (0.17 M sodium phosphate, pH 8 ) having dithiothreitol (DTT) for 16 hr. The oligonucleotides were separated from the by-products of the DTT reaction using size exclusion chromatography (NAP 10 column from Pharmacia Biotech) following the manufacturer's instructions. 10 mM sodium phosphate buffer (pH 6.8) was used to equilibrate the column and to elute the oligonucleotides. The concentration of the resulting DNA solution was calculated from the absorbance of the solution at 260 nm. In the case of primary DNA (i.e., the DNA used to form the master), 1M potassium phosphate buffer solution (pH 3.8) was added to the DNA solution to increase the ionic strength of the solution. The final concentration of DNA was 4-5 μΜ.
In the case of secondary DNA solution (i.e., DNA used to form the complement image), 1M NaCl in TE buffer (lOmM Tris buffer pH 7.2 and lmM EDTA) was added to increase the ionic strength of the solution. The secondary DNA used was purchased from Integrated DNA Technologies, Inc. (IDT), Coraville, LA and had the following structure 5 V5ThiolMC6-D/AAG AGC CCG AAG TTG CGT - 3'.
B. Preparation of a Master having a DNA Monolayer Clean and atomically flat gold on mica was used as a substrate. This substrate was placed in the primary DNA solution prepared above for 5 days to allow the DNA to bind to the surface of the substrate. The substrate was.rinsed with 1M potassium phosphate buffer 2 times and with water 5 times. The substrate was exposed to 1 mM spacer thiol, 6-mercapto-l-hexanol, aqueous solution for 2 hr to miniinize nonspecific adsorption of single-stranded DNA, then rinsed with water 5 times.
C. Preparation of Complement Image The master prepared in step B was dipped into the secondary DNA solution for 2 hours to allow the complementary DNA to hybridize to the DNA bound to the master. The substrate was rinsed with 1M NaCl in TE buffer 2 times and with water 5 times.
A second clean gold on mica substrate was placed in contact with the master so that the two gold surfaces were facing each other and had a small amount of water in between them. A small mechanical force was applied to push the two substrates together. As water between two substrates was evaporating, the spacing between the surfaces decreased due to increasing capillary attraction forces. Consequently, thiol groups of secondary DNA approached the second substrate and bound to it. After about 5 hr, the substrates were dipped into IM NaCl in TE buffer solution (70°C) for 20 min. The substrates (i.e., the master and the complement image) spontaneously separated and were rinsed with IM NaCl in TE buffer 2 times and with water 5 times, then air-dried. Both the master (see Figs. 3A and 3B) and the complement image (see Figs. 3C and 3D) were imaged using AFM tapping mode.
D. Results The coverage of the first substrate surface with DNA was complete. The thorough coverage made AFM imaging difficult due to strong interaction between monolayer and a tip. The layer transferred to the second substrate also had complete coverage.
Example 2: Pattern Transfer of Gold Grid An AFM calibration gold grid was dipped in 4 μΜ solution of the primary DNA molecules described in Example 1 for 5 days to generate a patterned master. The master was exposed to 1 mM 6-mercapto-l-hexanol aqueous solution for 2 hr to minimize nonspecific adsorption of single-stranded DNA, then rinsed with water 5 times and air-dried. The master was then exposed to a 6 μΜ solution of the secondary DNA described in Example 1 for 2 hours so that hybridization occurred. A second substrate of gold on mica was placed on the master so that the two gold surfaces were facing each other and had a small amount of water in between them. A small mechanical force was applied to force the two substrates together. After about 5 hr, the substrates were dipped into IM NaCl in TE buffer solution (70°C) for 20 min. The two substrates (i.e., master and the complement image) spontaneously separated and were rinsed with IM NaCl in TE buffer 2 times and with water 5 times, men air-dried. Both 0 1 T/U 20 5 012399 the master and the complement image were imaged using AFM tapping mode (see Figs. 4 A and 4B, respectively).
Example 3: Fabrication of a DNA Chip A master is prepared using Dip Pen Nanolithography, as described in Demer, et ai, Angew. Chem, Int. Ed (2001), 40: 3071-3073, the entire teachings of which are incorporated herein by reference. To prepare the master, a surface of a gold on mica substrate is contacted with a 1 mM solution of l-octadecanethiol (ODT) in ethanol for 5 min. to cover the exposed gold surface with ODT molecules. The substrate is then immersed in a 1 mM solution of 1,16-mercaptohexadecanoic acid (MHA) and the tip of an atomic force microscope is used to displace ODT molecules bound to the surface by contacting the surface with a force of about 0.5 nN making a 100 nm dot . The MHA in solution binds to the exposed gold surface of the dot. The carboxylic acid groups of the MHA are activated with a 10 mg/mL solution of l-ethyl-3-(3~ dimemylaminoproppyl)carbodiimide hydrochloride (ED AC) in 0.1 M morpholine/ethanesulfonic acid atpH 4.5, and then rinsed with a solution of 0.1M sodium borate/boric acid buffer, pH 9.5. A 25 uM solution of a DNA modified with a 1-n-hexyl amine group in the borate buffer is placed on the surface of the substrate. The amine groups of the DNA bind to the activated MHA molecules forming a DNA dot having a 100 nm diameter. The procedure of forming an MHA dot and binding a DNA molecule to it is repeated many more times with different amine modified DNA molecules to form a master having a DNA array with feature of about 100 nm.
The master is used to print a complement image array of DNA sequences on a second substrate in which each DNA sequence is complementary to one of the DNA molecules on the master and is located at a position on the second substrate that is a mirror image of its complementary sequence on the master. The complement image array is prepared by modifying a set of DNA molecules that includes all of the DNA molecules that are complementary to the DNA molecules on the master with a hexyl thiol linker. The thiol modified DNA molecules are placed in a phosphate buffer having a pH of 6.8 and 1 M NaCl. The master is immersed in the solution containing the thiol modified DNA molecules for 2 hrs, then master is removed from the solution and rinsed with 1 M NaCl in TE buffer once and with water five times.
A second clean gold on mica substrate is placed in contact with the master so that the two gold surfaces are facing each other and have a small amount of water in between them. A small mechanical force is applied to push the two substrates together. As water between the two substrates evaporates, the spacing between the surfaces decreases due to increasing capillary attraction forces. Consequently, thiol groups of the thiol modified DNA molecules approach the second substrate and bind to it. After about 5 hrs, the substrates are dipped into 1M NaCl in TE buffer solution (70°C) for 20 min. The substrates spontaneously separate and are rinsed with 1M NaCl in TE buffer 2 times and with water five times, then allowed to air dry. The master can be used to prepare one or more additional complement images.
Example 4: Preparation of a Complement Image of a DNA Array A DNA chip is purchased and used as a primary master. The DNA chip has a 12 x 12 square array in which each square is 300 nm x 300 nm and has a different DNA sequence attached to a substrate for a total of 144 different DNA sequences. The 300 nm x 300 nm squares are spaced 100 nm apart along the x- and y-axis of the surface of the substrate.
The master is used to print a 12 x 12 complement image array of DNA sequences on a second substrate in which each DNA sequence is complementary to one of the DNA molecules on the master and is located at a position on the second substrate that is a inirror image of its complementary sequence on the master. A set of DNA molecules that includes all of the DNA molecules that are complementary to the DNA molecules on the master (i.e., 144 different complementary DNA sequences) are modified with a hexyl thiol linker. The thiol modified DNA molecules are placed in a phosphate buffer having a pH of 6.8 and 1 M NaCl. The master is immersed in the solution containing the thiol modified DNA molecules for 2 hrs, then master is removed from the solution and rinsed with 1 M NaCl in TE buffer once and with water five times.
A clean gold on mica substrate is placed in contact with the master so that the gold surface of the new substrate is facing the 12 x 12 array of DNA molecules. A small amount of water is in between the two surfaces. A small mechanical force is applied to push the two substrates together. As water between the two substrates evaporates, the spacing between the surfaces decreases due to increasing capillary attraction forces. Consequently, thiol groups of the thiol modified DNA molecules approach the second substrate and bind to it. After about 5 hrs, the substrates are dipped into lMNaCl in TE buffer solution (70°C) for 20 min. The substrates spontaneously separate and are rinsed with 1 NaCl in TE buffer 2 times and with water five times, then allowed to air dry. The complement image has a 12 x 12 array of DNA molecules that are complementary to the DNA molecules on the master. The master can be used to prepare one or more additional complement image arrays following the same procedure.
In addition, the primary master can be replicated one or more times by following the procedure, as described above, except that the complement image is used in place of the master and a third set of 144 DNA molecules having the same sequences as the DNA molecules on the primary master and modified with a hexyl thiol linker is assembled on the complement image. A third substrate of gold on mica is then brought in contact with the complement image as described above for the primary master and the second substrate. The third set of DNA bound to the third substrate and separated from the complement image is a replica of the primary master.
Other embodiments of the invention will be apparent to those skilled in the art from a consideration of the specification or practice of the invention disclosed herein. It is intended that the specification and examples be considered as exemplary only, with the true scope and spirit of the invention being indicated by the following claims.
Claims (2)
1. 86468/2 A method of foraiing a complement image of a master, comprising the steps of: providing a master that comprises a first set of molecules bound to a first substrate to form a pattern; assembling via attractive forces or bond formation a second set of molecules on the first set of molecules, wherein each molecule in the second set of molecules comprises: i) a reactive functional group; and ii) a recognition component that is attracted to or binds to one or more of the first set of molecules; and iii) optionally a covalent bond or a first spacer that links the reactive functional group to the recognition component. "contacting the reactive functional group of the second set of molecules " with a surface of a second substrate, thereby forming a bond between the second set of molecules and said surface of a second substrate such that the second set of molecules are attached to said surface of said second substrate by bonds that are stable to conditions that will break the bonds between the first and the second set of molecules; breaking the attractive force or bonds between the first set of molecules and the second set of molecules by using a solution having a high ionic strength thereby forming a complement image of the master; and optionally repeating steps b) through d) one or more times.
2. The method of Claim 1 , further comprising the steps of: a) forming a pattern of one or more metal, metal oxide, or combinations thereof on a surface of a substrate using electron beam lithography; b) contacting the surface with the first set of molecules, wherein each molecule of the first set of molecules has a reactive functional group that forms a bond between the metal or metal oxide and the molecules of the first set of molecules, thereby forming a master that comprises a first set of molecules bound to the substrate to form a pattern. 186468/2 The method of Claim 1 , wherein at least one portion of the second substrate surface is free of the second set of molecules. The method of Claim 3, further comprising the steps of: a) contacting the surface of the second substrate with a reactant selected to be chemically inert to the second set of molecules and to degrade at least the surface layer of the second substrate, thereby degrading the portion of the surface of the second substrate that is free of the second set of molecules; and b) removing the second set of molecules to uncover a portion of the surface of the second substrate. The method of Claim 3, further comprising the steps of: a) depositing a material on the portion of the second substrate surface that is free of the second set of molecules; and b) removing the second set of molecules to uncover a portion of the surface of the second substrate. A method of forming a reproduction of a master, or portion thereof, comprising the steps of: a) providing a master that comprises a first set of molecules bound to a first substrate to form a pattern; b) assembling via bond formation a second set of molecules on the first set of molecules, wherein each molecule in the second set of molecules comprises: i) a reactive functional group; and ii) a recognition component that binds to the first set of molecules; and iii) optionally a covalent bond or a first spacer that links the reactive functional group to the recognition component. c) contacting the reactive functional group of the second set of molecules with a surface of a second substrate, thereby forming a bond between the second set of molecules and said surface of a second substrate such that the second set of molecules are attached to said surface of said second 186468/2 substrate by bonds that are stable to conditions that will break the bonds between the first and the second set of molecules; breaking the bonds between the first set of molecules and the second set of molecules by using a solution having a high ionic strength thereby forming a complement image of the master; assembling via bond formation a third set of molecules on the second set of molecules of the complement image, wherein each molecule in the third set of molecules consists of: i) a reactive functional group; and ii) a recognition component that binds to the second set of molecules; and iii) optionally a covalent bond or a first spacer that links the reactive functional group to the recognition component. contacting the reactive functional group of the third set of molecules with a surface of a third substrate, thereby forming a bond between the third set of molecules and said surface of a third substrate such that the third set of molecules are attached to said surface of said third substrate by bonds that are stable to conditions that will break the bonds between the second and the third set of molecules; breaking the bonds between the second set of molecules and the third set of molecules by using a solution having a high ionic strength thereby forming the reproduction of the master, or portion thereof; and optionally repeating steps e) through g) one or more times. 7. The method of Claim 6, further comprising the steps of: a) forming a pattern of one or more metal, metal oxide, or combinations thereof on a surface of a substrate using electron beam lithography; b) contacting the surface with the first set of molecules, wherein each molecule of the first set of molecules has a reactive functional group that forms a bond between the metal or metal oxide and the molecules of the first set of molecules, thereby forming a master that comprises a first set of molecules bound to the substrate to form a pattern. 8. The method of Claim 6, wherein at least one portion of the third substrate surface is 186468/2 free of the third set of molecules. 9. The method of Claim 8, further comprising the steps of: a) contacting the surface of the third substrate with a reactant selected to be chemically inert to the third set of molecules and to degrade at least the surface layer of the third substrate, thereby degrading the portion of the surface of the third substrate that is free of the third set of molecules; and b) removing the third set of molecules to uncover a portion of the surface of the third substrate. The method of Claim 8, further comprising the steps of: a) depositing a material on the portion of the third substrate surface that is free of the third set of molecules; and b) removing the third set of molecules to uncover a portion of the surface of the third substrate. 1 1. A method of forming a complement image of a master, comprising the steps of: a) providing a master that comprises a first set of molecules bound to a first substrate to form a pattern; b) assembling via attractive forces or bond formation a second set of molecules on the first set of molecules, wherein each molecule in the second set of molecules consists of: i) a reactive functional group; and ii) a recognition component that is attracted to or binds to one or more of the first set of molecules; and iii) optionally a covalent bond or a first spacer that links the reactive functional group to the recognition component. iv) An exposed functionality selected from the group consisting of: antibody, antigen, hapten, enzyme, a substrate for an enzyme, inhibitor, co-factor, protein, lectin, carbohydrate, receptor, hormone, effector, repressor/inducer, or chemical groups such as— OH,— CONH— ,— CONHCO— ,— NH2,— NH— ,— COOH,— COOR, 186468/2 — CSNH— ,— 02",— S02,— SH,— RCOR—— RCSR— ,— RSR,— ROR—— P043",— OSO32',— S03",— COO",— SOO\— RSOR— — CONR2, — (OCH2CH2)nOH (wherein n = 1-20, preferably 1-8),— CH3,— P03H",— 2-imidazole,— N(CH3)2}— N(R>2,— P03H2,— CN,— (CF2)nCF3 (wherein n = 1-20, preferably 1-8), an olefin; wherein R is hydrogen, a hydrocarbon, a halogenated hydrocarbon, a protein, an enzyme, a carbohydrates, a lectin, a hormone, a receptor, an antigen, an antibody, or a hapten, v) optionally a covalent bond or a second spacer that links the exposed functionality to the recognition component. c) contacting the reactive functional group of the second set of molecules with a surface of a second substrate, thereby forming a bond between the second set of molecules and said surface of a second substrate such that the second set of molecules are attached to said surface of said second substrate by bonds that are stable to conditions that will break the bonds between the first and the second set of molecules; d) breaking the attractive force or bonds between the first set of molecules and the second set of molecules by using a solution having a high ionic strength thereby forming a complement image of the master; and e) optionally repeating steps b) through d) one or more times. 12. A method of forming a reproduction of a master, or portion thereof, comprising the steps of: a) providing a master that comprises a first set of molecules bound to a first substrate to form a pattern; b) assembling via bond formation a second set of molecules on the first set of molecules, wherein each molecule in the second set of molecules consists of: i) a reactive functional group; and ii) a recognition component that binds to the first set of molecules; and iii) optionally a covalent bond or a first spacer that links the reactive functional group to the recognition component. 186468/2 iv) optionally an exposed functionality selected from the group consisting of: antibody, antigen, hapten, enzyme, a substrate for an enzyme, inhibitor, co-factor, protein, lectin, carbohydrate, receptor, hormone, effector, repressor/inducer, or chemical groups such as—OH,— CONH— ,— CONHCO— ,— NH2,— NH— ,— COOH,— COOR,— CSNH— ,— N02",— S02,— SH,— RCOR— ,— RCSR— ,— RSR,— ROR— ,— PO„3",— OS032',— S03\—COO",— SOO\— RSOR— ,— CONR2,— (OCH2CH2)nOH (wherein n - 1 -20, preferably 1 -8),— CH3,— PO3H',— 2-imidazole,— N(CH3)2,— N(R)2,— P03H2,— CN, — (CF2)nCF3 (wherein n = 1-20, preferably 1-8), an olefin; wherein R is hydrogen, a hydrocarbon, a halogenated hydrocarbon, a protein, an enzyme, a carbohydrates, a lectin, a hormone, a receptor, an antigen, an antibody, or a hapten. v) optionally a covalent bond or a second spacer that links the exposed functionality to the recognition component. contacting the reactive functional group of the second set of molecules with a surface of a second substrate, thereby forming a bond between the second set of molecules and said surface of a second substrate such that the second set of molecules are attached to said surface of said second substrate by bonds that are stable to conditions that will break the bonds between the first and the second set of molecules; breaking the bonds between the first set of molecules and the second set of molecules by using a solution having a high ionic strength thereby forming a complement image of the master; assembling via bond formation a third set of molecules on the second set of molecules of the complement image, wherein each molecule in the third set of molecules consists of: i) a reactive functional group; and ii) a recognition component that binds to the second set of molecules; and iii) optionally a covalent bond or a first spacer that links the reactive functional group to the recognition component. iv) An exposed functionality selected from the group consisting of: 186468/2 antibody, antigen, hapten, en2yme, a substrate for an enzyme, inhibitor, co-factor, protein, lectin, carbohydrate, receptor, hormone, effector, repressor/inducer, or chemical groups such —OH, — CONH— — CONHCO— , — ¾, — NH— , — COOH, — COOR, — CSNH— , — N02\ — S02; — SH, — RCOR— — RCSR— — SR,— ROR— — P043',— OS032", — S03\ —COO", — SOO", — RSOR— , — CONR2, — (OCH2CH2)nOH (wherein n = 1-20, preferably 1-8),— CH3,— PO3H-,— 2-imidazole,— N(CH3)2,— N(R)2,— P03H2,— CN, — (CF2)nCF3 (wherein n = 1-20, preferably 1-8), an olefin; wherein R is hydrogen, a hydrocarbon, a halogenated hydrocarbon, a protein, an enzyme, a carbohydrates, a lectin, a hormone, a receptor, an antigen, an antibody, or a hapten. v) optionally a covalent bond or a second spacer that links the exposed functionality to the recognition component, contacting the reactive functional group of the third set of molecules with a surface of a third substrate, thereby forming a bond between the third set of molecules and said surface of a third substrate such that the third set of molecules are attached to said surface of said third substrate by bonds that are stable to conditions that will break the bonds between the second and the third set of molecules; breaking the bonds between the second set of molecules and the third set of molecules by using a solution having a high ionic strength thereby forming the reproduction of the master, or portion thereof; and optionally repeating steps e) through g) one or more times. Respectfully submitted, Pearl Cohen Zedek Latzer Advocates, Patent Attorneys & Notaries P-8698-IL
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2005/012399 WO2006112815A2 (en) | 2005-04-12 | 2005-04-12 | Nanocontact printing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL186468A0 IL186468A0 (en) | 2008-01-20 |
| IL186468A true IL186468A (en) | 2013-02-28 |
Family
ID=37115593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL186468A IL186468A (en) | 2005-04-12 | 2007-10-07 | Method of forming a complement image of a master |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1877245A4 (en) |
| JP (1) | JP4954196B2 (en) |
| KR (1) | KR101205937B1 (en) |
| CN (1) | CN101218089B (en) |
| AU (1) | AU2005330718B2 (en) |
| IL (1) | IL186468A (en) |
| WO (1) | WO2006112815A2 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009502529A (en) * | 2005-07-28 | 2009-01-29 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Composition and use thereof |
| DE102007024653A1 (en) | 2007-05-26 | 2008-12-04 | Forschungszentrum Karlsruhe Gmbh | Stamp for microcontact printing and process for its preparation |
| ITBO20070627A1 (en) * | 2007-09-14 | 2009-03-15 | Twof Inc | METHOD FOR THE PREPARATION OF MICROARRAY DNA WITH HIGH LINEAR DENSITY PROBES |
| ITTO20090860A1 (en) * | 2009-11-10 | 2011-05-11 | Molecular Stamping S R L | METHOD FOR MAKING LONG OLIGONUCLEOTID AND MICROARRAY MICROARRAYS WITH LONG OLIGONUCLEOTIDS |
| GB201108041D0 (en) * | 2011-05-13 | 2011-06-29 | Univ Portsmouth | Method |
| JP6458290B2 (en) | 2014-03-28 | 2019-01-30 | リンテック株式会社 | Protective film forming film and method of manufacturing semiconductor chip with protective film |
| WO2016026924A1 (en) * | 2014-08-21 | 2016-02-25 | Illumina Cambridge Limited | Reversible surface functionalization |
| EP3147708B1 (en) * | 2015-08-21 | 2018-11-28 | Samsung Electronics Co., Ltd. | Photosensitive compositions, preparation methods thereof and quantum dot polymer composite prepared therefrom |
| KR102149907B1 (en) * | 2016-03-03 | 2020-08-31 | 어플라이드 머티어리얼스, 인코포레이티드 | Improved self-assembly monolayer blocking by periodic air-water exposure |
| US12465902B2 (en) | 2018-05-15 | 2025-11-11 | Biocopy Gmbh | Microarray transformer |
| DE102021109811B3 (en) | 2021-04-19 | 2022-09-22 | Biocopy Gmbh | Process for the production of complex arrays |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5605662A (en) * | 1993-11-01 | 1997-02-25 | Nanogen, Inc. | Active programmable electronic devices for molecular biological analysis and diagnostics |
| SE9504347D0 (en) * | 1995-12-01 | 1995-12-01 | Boerje Sellergren | Surface modification technique |
| EP1131153A1 (en) * | 1998-11-06 | 2001-09-12 | Solexa Ltd. | A method for reproducing molecular arrays |
| DE19854946C2 (en) * | 1998-11-27 | 2002-01-03 | Guenter Von Kiedrowski | Cloning and copying on surfaces |
| US6635311B1 (en) * | 1999-01-07 | 2003-10-21 | Northwestern University | Methods utilizing scanning probe microscope tips and products therefor or products thereby |
| US6514768B1 (en) | 1999-01-29 | 2003-02-04 | Surmodics, Inc. | Replicable probe array |
| US7135143B2 (en) * | 2001-03-14 | 2006-11-14 | Wisconsin Alumni Research Foundation | Detecting compounds with liquid crystals |
| EP1546396A4 (en) * | 2002-10-02 | 2006-10-18 | New Light Ind Ltd | Manufacturing method and readout system for biopolymer arrays |
-
2005
- 2005-04-12 AU AU2005330718A patent/AU2005330718B2/en not_active Ceased
- 2005-04-12 JP JP2008506422A patent/JP4954196B2/en not_active Expired - Fee Related
- 2005-04-12 CN CN2005800501019A patent/CN101218089B/en not_active Expired - Fee Related
- 2005-04-12 WO PCT/US2005/012399 patent/WO2006112815A2/en not_active Ceased
- 2005-04-12 KR KR1020077026269A patent/KR101205937B1/en not_active Expired - Fee Related
- 2005-04-12 EP EP05825476A patent/EP1877245A4/en not_active Withdrawn
-
2007
- 2007-10-07 IL IL186468A patent/IL186468A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008538410A (en) | 2008-10-23 |
| EP1877245A4 (en) | 2012-08-15 |
| AU2005330718B2 (en) | 2011-05-12 |
| WO2006112815A3 (en) | 2006-12-14 |
| HK1121719A1 (en) | 2009-04-30 |
| KR101205937B1 (en) | 2012-11-28 |
| CN101218089B (en) | 2011-06-08 |
| CN101218089A (en) | 2008-07-09 |
| AU2005330718A1 (en) | 2006-10-26 |
| KR20080016551A (en) | 2008-02-21 |
| EP1877245A2 (en) | 2008-01-16 |
| WO2006112815A2 (en) | 2006-10-26 |
| JP4954196B2 (en) | 2012-06-13 |
| IL186468A0 (en) | 2008-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7862849B2 (en) | Nanocontact printing | |
| IL186468A (en) | Method of forming a complement image of a master | |
| Köhler et al. | Nanotechnology: an introduction to nanostructuring techniques | |
| Ruiz et al. | Microcontact printing: A tool to pattern | |
| US7491422B2 (en) | Direct-write nanolithography method of transporting ink with an elastomeric polymer coated nanoscopic tip to form a structure having internal hollows on a substrate | |
| Michel et al. | Printing meets lithography: Soft approaches to high-resolution patterning | |
| Woodson et al. | Functional nanostructures from surface chemistry patterning | |
| KR100939421B1 (en) | Direct Writing of Nucleic Acids from Nanoscopic Tips | |
| CN102037407A (en) | Polymer pen lithography | |
| EP2122417B1 (en) | Fabrication of microstructures and nanostructures using etching resist | |
| Tseng et al. | Nanoscale fabrication by nonconventional approaches | |
| US8383339B2 (en) | Liquid supramolecular nanostamping (LiSuNS) | |
| US20080272516A1 (en) | Successive Shrinking of Elastomers - a Simple Miniaturization Protocol to Produce Micro- and Nano-Structures | |
| Akbulut et al. | Fabrication of biomolecular devices via supramolecular contact-based approaches | |
| HK1121719B (en) | Nanocontact printing | |
| JP2012029694A (en) | Nanocontact printing | |
| CA2523896A1 (en) | Nanocontact printing | |
| Rahman et al. | Two-dimensional materials as substrates for the development of origami-based bionanosensors | |
| Takulapalli et al. | A nanocontact printing system for sub-100 nm aligned patterning | |
| Rivas-Cordona et al. | Fabrication of a microfluidic device for simultaneous patterning of multiple chemical species by dip pen nanolithography (DPN) | |
| Mizuno | Development of catalytic stamp lithography for nanoscale patterning of organic monolayers | |
| Zauscher et al. | Scanning probe lithography: polymeric and biomolecular nanostructures | |
| Basnar | Nanopattern formation using dip-pen nanolithography | |
| Yu | Supramolecular NanoStamping (SuNS): fabricating nano/bio devices using DNA as a movable type | |
| Tseng et al. | Nanoscale Fabrication |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| MM9K | Patent not in force due to non-payment of renewal fees |